Filing Flows › GeneDx Holdings (WGS) › Free cash flow
GeneDx Holdings (WGS) free cash flow by quarter
GeneDx Holdings' free cash flow was $9.6M in Q3 2025 (third quarter 2025), +19% from Q2 2025. Over the last 3 quarters it ranged from $4.1M (Q1 2025) to $9.6M (Q3 2025).
| Quarter | Free cash flow | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2025 | $9.6M | +19% | — |
| Q2 2025 | $8.1M | +99% | — |
| Q1 2025 | $4.1M | — | — |
Q3 2025 at a glance
GeneDx Holdings, Q3 2025: revenue $117M (+52% year over year), operating margin -2.8%, net loss $7.6M, operating cash flow $15.8M. The chart follows the revenue to costs, profit and cash.
Questions
What is GeneDx Holdings' free cash flow?
GeneDx Holdings' free cash flow was $9.6M in Q3 2025 (third quarter 2025), +19% from Q2 2025.
How has GeneDx Holdings' free cash flow changed?
Over the last 3 quarters it ranged from $4.1M (Q1 2025) to $9.6M (Q3 2025).